Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms
J Psychiatry Neurosci
.
2023 May 12;48(3):E149-E150.
doi: 10.1503/jpn.220216.
Print 2023 May-Jun.
Authors
Nicolas Garel
1
,
Christina Rigas
1
,
Mona Ben M'rad
1
,
Katie Bodenstein
1
,
Ridha Joober
1
,
Harmehr Sekhon
1
,
Soham Rej
1
Affiliation
1
From McGill University, Psychiatry residency & Clinician Investigator programs, Montréal, Que. (Garel); McGill University, Department of Psychiatry, Montréal, Que. (Rigas, Ben m'rad, Bodenstein); the Haut-Richelieu Hospital, Nephrology Department, Saint-Jean-sur-Richelieu, Que. (Ben m'rad); McGill University, Douglas Mental Health University Institute, Montréal, Que. ( Joober); McGill University, Jewish General Hospital ( Sekhon); McGill University, Jewish General Hospital, Montréal, Que. (Rej).
PMID:
37172961
PMCID:
PMC10185346
DOI:
10.1503/jpn.220216
No abstract available
MeSH terms
Anxiety / drug therapy
Benzodiazepines
Deprescriptions*
Depression / drug therapy
Humans
Mindfulness*
Renal Dialysis
Substances
Benzodiazepines